Pharmala Biotech Holdings Inc. (MDMA.CN)
CAD 0.17
(10.0%)
CAD 0.17
(10.0%)
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2023 | -762.95 Thousand CAD | 24.3% |
| 2022 | -985.58 Thousand CAD | 60.72% |
| 2021 | -2.5 Million CAD | 0.0% |
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2024 Q2 | -222.57 Thousand CAD | -208.09% |
| 2024 Q1 | 205.9 Thousand CAD | 131.37% |
| 2024 Q3 | -413.15 Thousand CAD | -85.63% |
| 2023 Q2 | -217.88 Thousand CAD | 24.48% |
| 2023 Q1 | -288.5 Thousand CAD | -50.69% |
| 2023 Q3 | -338.74 Thousand CAD | -55.47% |
| 2023 FY | -746.08 Thousand CAD | 24.3% |
| 2023 Q4 | 88.99 Thousand CAD | 126.27% |
| 2022 Q2 | -285.33 Thousand CAD | 5.74% |
| 2022 Q1 | -302.72 Thousand CAD | 0.0% |
| 2022 Q3 | -206.08 Thousand CAD | 27.78% |
| 2022 FY | -985.58 Thousand CAD | 60.72% |
| 2022 Q4 | -191.44 Thousand CAD | 7.1% |
| 2021 Q3 | -2.31 Million CAD | 0.0% |
| 2021 FY | -2.5 Million CAD | 0.0% |
| Name | Operating Income | Operating Income Difference |
|---|---|---|
| Algernon Pharmaceuticals Inc. | -5.01 Million CAD | 84.796% |
| Asep Medical Holdings Inc | -7.72 Million CAD | 90.119% |
| BetterLife Pharma Inc. | -3.24 Million CAD | 76.454% |
| BioVaxys Technology Corp. | -2.4 Million CAD | 68.245% |
| ChitogenX Inc. | -2.83 Million CAD | 73.041% |
| Rapid Dose Therapeutics Corp. | -3.73 Million CAD | 79.594% |
| Defence Therapeutics Inc. | -12.65 Million CAD | 93.972% |
| Entheon Biomedical Corp. | -313.99 Thousand CAD | -142.984% |
| Gemina Laboratories Ltd. | -5.08 Million CAD | 84.999% |
| Glow Lifetech Corp. | -1.64 Million CAD | 53.555% |
| Lexston Life Sciences Corp. | -674.71 Thousand CAD | -13.077% |
| Doseology Sciences Inc. | -377.63 Thousand CAD | -102.035% |
| MYND Life Sciences Inc. | -1.8 Million CAD | 57.796% |
| Nova Mentis Life Science Corp. | -1.2 Million CAD | 36.542% |
| PharmaTher Holdings Ltd. | -3.04 Million CAD | 74.937% |
| PreveCeutical Medical Inc. | -963.12 Thousand CAD | 20.784% |
| Telescope Innovations Corp. | -5.76 Million CAD | 86.77% |